SE405851B - Forfarande for framstellning av nya 2-aminometylenindanoner med analgetisk verkan - Google Patents

Forfarande for framstellning av nya 2-aminometylenindanoner med analgetisk verkan

Info

Publication number
SE405851B
SE405851B SE7316447A SE7316447A SE405851B SE 405851 B SE405851 B SE 405851B SE 7316447 A SE7316447 A SE 7316447A SE 7316447 A SE7316447 A SE 7316447A SE 405851 B SE405851 B SE 405851B
Authority
SE
Sweden
Prior art keywords
innanons
aminomethylene
procedure
manufacture
new
Prior art date
Application number
SE7316447A
Other languages
English (en)
Swedish (sv)
Other versions
SE7316447L (xx
Inventor
P D Hammen
Milne Jr G Mclean
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE7316447L publication Critical patent/SE7316447L/xx
Publication of SE405851B publication Critical patent/SE405851B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C225/00Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
    • C07C225/02Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C225/14Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated
    • C07C225/16Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings
    • C07C225/18Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being unsaturated and containing six-membered aromatic rings the carbon skeleton containing also rings other than six-membered aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7316447A 1972-12-06 1973-12-05 Forfarande for framstellning av nya 2-aminometylenindanoner med analgetisk verkan SE405851B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/312,693 US4022836A (en) 1972-12-06 1972-12-06 2-Aminomethyleneindanone analgesic agents

Publications (2)

Publication Number Publication Date
SE7316447L SE7316447L (xx) 1974-06-07
SE405851B true SE405851B (sv) 1979-01-08

Family

ID=23212586

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7316447A SE405851B (sv) 1972-12-06 1973-12-05 Forfarande for framstellning av nya 2-aminometylenindanoner med analgetisk verkan

Country Status (20)

Country Link
US (2) US4022836A (xx)
JP (1) JPS5542066B2 (xx)
AR (1) AR207946A1 (xx)
AT (1) AT326646B (xx)
BE (1) BE808275A (xx)
CA (1) CA1002068A (xx)
CH (1) CH584677A5 (xx)
DE (1) DE2360096C2 (xx)
DK (1) DK139575B (xx)
ES (1) ES421167A1 (xx)
FR (1) FR2209565B1 (xx)
GB (1) GB1448026A (xx)
IE (1) IE38553B1 (xx)
IL (1) IL43722A (xx)
LU (1) LU68950A1 (xx)
NL (1) NL172057C (xx)
NO (1) NO137858C (xx)
PH (1) PH10690A (xx)
SE (1) SE405851B (xx)
ZA (1) ZA739052B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4164514A (en) * 1972-12-06 1979-08-14 Pfizer Inc. 2-Aminomethyleneindanone analgesic agents
US4117012A (en) * 1972-12-06 1978-09-26 Pfizer Inc. 2-aminomethyleneindanone analgesic agents
US4334085A (en) * 1978-09-14 1982-06-08 Standard Oil Company (Indiana) Transamination process for Mannich products
NZ209534A (en) * 1983-09-30 1987-01-23 Surgikos Inc Antimicrobial fabric for surgical drape
US6369289B1 (en) 2000-07-07 2002-04-09 Tyco Healthcare Group Lp Method and manufacture of a wound dressing for covering an open wound
DE60234057D1 (de) 2001-07-25 2009-11-26 Raptor Pharmaceutical Inc Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
EP2392258B1 (en) 2005-04-28 2014-10-08 Proteus Digital Health, Inc. Pharma-informatics system
US8795627B2 (en) 2007-03-21 2014-08-05 Raptor Pharmaceuticals Inc. Treatment of liver disorders by administration of RAP conjugates
AU2010216512B2 (en) 2009-02-20 2016-06-30 2-Bbb Medicines B.V. Glutathione-based drug delivery system
WO2010129819A2 (en) 2009-05-06 2010-11-11 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3454565A (en) * 1966-10-05 1969-07-08 American Cyanamid Co Novel indanones

Also Published As

Publication number Publication date
NL7316663A (xx) 1974-06-10
DE2360096C2 (de) 1982-07-01
NL172057C (nl) 1983-07-01
NO137858B (no) 1978-01-30
GB1448026A (en) 1976-09-02
IL43722A (en) 1976-03-31
IL43722A0 (en) 1974-03-14
NL172057B (nl) 1983-02-01
FR2209565A1 (xx) 1974-07-05
JPS5542066B2 (xx) 1980-10-28
DK139575C (xx) 1979-08-27
IE38553L (en) 1974-06-06
PH10690A (en) 1977-08-10
US4022836A (en) 1977-05-10
SE7316447L (xx) 1974-06-07
BE808275A (fr) 1974-06-06
DK139575B (da) 1979-03-12
ES421167A1 (es) 1976-04-01
JPS4986352A (xx) 1974-08-19
CA1002068A (en) 1976-12-21
AT326646B (de) 1975-12-29
LU68950A1 (xx) 1974-07-05
DE2360096A1 (de) 1974-07-04
NO137858C (no) 1978-05-10
AU6302373A (en) 1975-05-29
FR2209565B1 (xx) 1977-04-08
CH584677A5 (xx) 1977-02-15
ATA1013873A (de) 1975-03-15
AR207946A1 (es) 1976-11-22
IE38553B1 (en) 1978-04-12
ZA739052B (en) 1974-10-30
US4064272A (en) 1977-12-20

Similar Documents

Publication Publication Date Title
SE382059B (sv) Forfarande for framstellning av nya substituerade piperidinderivat
SE386445B (sv) Forfaranden for framstellning av nya bensotiadiazoler
NO140731C (no) Fremgangsmaate for fremstilling av dimetyleter
SE394426B (sv) Forfarande for framstellning av nya heptapeptider med gastrinverkan
SE382060B (sv) Forfarande for framstellning av nya substituerade piperidinoalkanonoximderivat
SE422801B (sv) Forfarande for framstellning av nya cefalosporinforeningar
SE420322B (sv) Anvendning av nya gamma-glutamyl-4-nitroanild-derivat for bestemning av gamma-glutsmyltranspeptidas
SE401186B (sv) Forfarande for framstellning av nya penicilliner
NO140478C (no) Fremgangsmaate for fremstilling av fibriller
SE380522B (sv) Forfarande for framstellning av (1- (p-klorbensoyl)-5-metoxi-2-metyl-3-indol) - acetoxiettiksyra med antiflogistisk verkan
SE384853B (sv) Forfarande for framstellning av nya aminer
SE405477B (sv) Forfarande for framstellning av tetrazolyl-kinaldinsyraderivat med farmakologisk verkan
SE405851B (sv) Forfarande for framstellning av nya 2-aminometylenindanoner med analgetisk verkan
SE413244B (sv) Forfarandefor framstellning av bensopyraner med analgetisk verkan
SE392609B (sv) Forfarande for framstellning av metanhaltiga gaser
SE396387B (sv) Forfarande for framstellning av 1-(2-karboxikromonyloxi)-2-hydroxi-3-p-cyanfenoxi-propaner med terapentisk verkan
SE403911B (sv) Forfarande for framstellning av aroylsubstituerade fenylettiksyraderivat med anti-inflammatorisk verkan
FI55998B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 2-alkylamino-dihydropyridiner
SE392722B (sv) Forfarande for framstellning av oxazolidinderivat med terapeutisk verkan
FI56830B (fi) Foerfarande foer framstaellning av asparaginylgrupper innehaollande biologiskt aktiva polypeptider
SE386681B (sv) Forfarande for framstellning av nya cefalosporinderivat
SE383631B (sv) Forfarande for framstellning av nya 1-fenoxi-2-hydroxid-3-hydroxialkylaminopropaner
FI56670B (fi) Foerfarande foer framstaellning av 5-cyklohexyl-6-halogenindan-1-karboxylsyraderivat
SE384027B (sv) Forfarande for framstellning av nya alfa-alkylsulfobensylpenicilliner
SE384210B (sv) Forfarande for framstellning av nya nitrosokarbamidderivat